Evidence map›Paper›PMID 40682655›Full record

ArticleBulletin of experimental biology and medicine2025

Secretome and Cellular Composition of Peripheral Blood Mononuclear Cells Cultured in the Presence of Cell Feeder or Interleukins.

J M Rozenberg, R V Zhurikov, A S Oleinik, S A Roumiantsev, E V Abakushina

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. NK cells in HPV-related tumorigenesis: mechanisms and clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J M RozenbergDepartment of Research and Development in Immunology, "Tecon MP" LLC, Moscow, Russia.
R V ZhurikovDepartment of Research and Development in Immunology, "Tecon MP" LLC, Moscow, Russia.
A S OleinikDepartment of Research and Development in Immunology, "Tecon MP" LLC, Moscow, Russia.
S A RoumiantsevNational Medical Research Center for Endocrinology, Ministry of Health of the Russian Federation, Moscow, Russia.
E V AbakushinaDepartment of Research and Development in Immunology, "Tecon MP" LLC, Moscow, Russia. abakushina@mail.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral blood mononuclear cells-derived immune cells are widely used in clinical practice, in particular for cancer therapy. The growth conditions are critical for the composition and functional activity of cells. Mononuclear cells were cultured for 15 days under different conditions: in the presence of K562 cell feeder expressing 4-1BBL and mbIL-21I, or without feeder, but in the presence of L-21 or with different combinations of cytokines (IL-2, IL-15, IL-21, and IL-12) without the feeder and the cytokine profile (48 cytokines) of the culture medium in the middle (day 7) and at the end (day 14) of culturing was compared. In the presence of the feeder, the cells produced IFNγ, RANTES, MIP-1α, IL-9, IL-6, and CF-CSF in high concentrations (> 5000 pg/ml) and less intensively produced MDC; NK cells predominated in the culture. These cytokines promote proliferation of immune cells, participate in antitumor response (IFNγ and RANTES) and have a dual effect on the growth of some tumor cell lines (IL-6, IL-9, and VEGF). The conditioned medium, especially the medium from mononuclears grown without feeder, inhibited the growth of lung cancer cell line A549. The studied methods for mononuclear cell culturing increase the functional and antitumor activities of NK cells via stimulation of cytokine production.

Indexed as

Feeder CellsInterleukinsLeukocytes, MononuclearSecretomeCell ProliferationChemokine CCL5Coculture TechniquesCulture Media, ConditionedCytokinesHumansInterferon-gammaInterleukin-21Interleukin-6K562 CellsKiller Cells, NaturalChemokine CCL5Culture Media, ConditionedCytokinesInterferon-gammaInterleukin-21Interleukin-6Interleukinscytokinesnatural killersperipheral blood mononuclear cellssecretome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.